UnitedHealth Group (UNH) Projected to Post Quarterly Earnings on Tuesday

UnitedHealth Group (NYSE:UNH) is expected to be issuing its Q1 2026 results before the market opens on Tuesday, April 21st. Analysts expect the company to announce earnings of $6.76 per share and revenue of $109.8394 billion for the quarter. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, April 21, 2026 at 8:00 AM ET.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same quarter last year, the company earned $6.81 EPS. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Stock Up 2.9%

UNH stock opened at $313.20 on Tuesday. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $595.63. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The firm has a market cap of $284.29 billion, a PE ratio of 23.75, a price-to-earnings-growth ratio of 1.40 and a beta of 0.40. The business has a 50 day moving average of $283.56 and a 200 day moving average of $317.94.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research analyst reports. Oppenheimer reduced their target price on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Mizuho reduced their target price on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a report on Thursday, February 5th. Wells Fargo & Company reduced their target price on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Weiss Ratings lowered UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. Finally, Barclays reduced their target price on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $363.42.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Medicare Advantage rate increase lifted sentiment and earlier sparked an ~8% rally, reinforcing revenue tailwinds for UnitedHealthcare’s MA business and supporting near-term earnings outlook. UnitedHealth (UNH) Stock Soars 8% on Medicare Advantage Rate Increase – Can Momentum Last?
• Positive Sentiment: BofA raised its price target on UNH (while keeping a Neutral rating), a signal that some sell-side analysts see more upside from improving fundamentals and the Medicare Advantage developments. Analyst support can help sustain buying interest. Analyst Raises Price Target on UnitedHealth Group (UNH), Keeps ‘Neutral’ Rating
• Positive Sentiment: Macro/sector rotation stories are lifting healthcare names; commentary suggesting UnitedHealth is a durable value play has attracted buy-side interest amid the recent pullback in the sector. The Great Rotation: Buy This Sector Before It Comes Back in Style
• Neutral Sentiment: Patient Capital Management’s Q1 letter says it remains committed to its UNH thesis despite short-term underperformance — a sign of continued institutional conviction but not an immediate catalyst. Patient Opportunity Equity Strategy Remains Firm on Its Thesis for UnitedHealth Group (UNH)
• Neutral Sentiment: Recent headlines noting UNH “outperformed the broader market” merely reflect the stock’s positive reaction to the items above; they summarize market moves but don’t add new fundamental information. UnitedHealth Group (UNH) Outperforms Broader Market: What You Need to Know
• Negative Sentiment: UnitedHealth announced pullbacks in 16 states after finding some Medicare Advantage plans unprofitable — this highlights execution risk and near-term membership/earnings volatility in the MA channel. Market Crash: This Dividend Stock Becomes a No-Brainer Buy at a Discount
• Negative Sentiment: Analysis noting a “broken trust” and a temporary margin reset underscores lingering investor concerns after guidance withdrawal; valuation still reflects uncertainty until margins and guidance are fully restored. UnitedHealth: Trust Is Broken – But The Model Isn’t

Institutional Trading of UnitedHealth Group

Several large investors have recently modified their holdings of the company. Caitlin John LLC grew its holdings in shares of UnitedHealth Group by 3.9% in the fourth quarter. Caitlin John LLC now owns 1,064 shares of the healthcare conglomerate’s stock worth $351,000 after acquiring an additional 40 shares during the period. Riggs Asset Managment Co. Inc. grew its holdings in shares of UnitedHealth Group by 69.4% in the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 43 shares during the period. Riverwater Partners LLC lifted its position in UnitedHealth Group by 1.9% during the fourth quarter. Riverwater Partners LLC now owns 2,458 shares of the healthcare conglomerate’s stock valued at $811,000 after purchasing an additional 45 shares in the last quarter. Safeguard Investment Advisory Group LLC lifted its position in UnitedHealth Group by 1.2% during the fourth quarter. Safeguard Investment Advisory Group LLC now owns 3,822 shares of the healthcare conglomerate’s stock valued at $1,262,000 after purchasing an additional 45 shares in the last quarter. Finally, Sittner & Nelson LLC lifted its position in UnitedHealth Group by 7.2% during the third quarter. Sittner & Nelson LLC now owns 682 shares of the healthcare conglomerate’s stock valued at $236,000 after purchasing an additional 46 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.